2011 Report on the state of the art of rare disease activities in Europe of the European Union Committee of Experts on Rare Diseases : Part II European Commission and European activities

The present report aims to provide an informative and descriptive overview of rare disease activities at European Union (EU) and Member State (MS) level in the field of rare diseases and orphan drugs up to the end of 2010. A range of stakeholders in each Member State have been consulted during the elaboration of the report, which has been validated as an accurate representation of activities at national level, to the best of their knowledge, by the Member State representatives of the European Union Committee of Experts on Rare Diseases. The reader, however, should bear in mind that the information provided is not exhaustive, and is not an official position of either the European Commission or national health authorities. The report is split into three parts: Part I: Overview of Rare Disease Activities in Europe and Key Developments in 2010 ; Part II: European Commission and other European activities ; Part III: Activities in EU Member States and other European Countries. Each part contains the following description of the methodology, sources and validation process of the entire report, and concludes with a selected bibliography and list of persons having contributed to the report